Skip to content

TSHATAYSHA GENE THERAPIES INC

CUSIP 877619106 · common stock

4 tracked investors held TAYSHA GENE THERAPIES INC (TSHA) at the end of Q3 2026, worth $185.1M in total. The largest holder was RA Capital Management, with 1.5% of its portfolio.

Holders · Q3 2026
4
New holders
0
Value held
$185.1M
Quarter-end price (est.)
$4.87

Investors holding TSHA · Q3 2026

InvestorWeightSharesValueChange
RA Capital Management
RA Capital Management, L.P.
1.49%30,435,190$148.2MADD+29.2%
Julian Baker
Baker Bros. Advisors LP
0.09%4,004,756$19.5MHOLD
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.63%3,059,567$14.9MADD+0.6%
Polen Capital Management
Polen Capital Management LLC
0.03%503,379$2.5MADD+2.9%

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026400$185.1M$4.87
Q2 2026400$211.7M$6.81
Q1 2026400$137.9M$4.47
Q4 2025400$166.2M$5.50